Indication

Generalized vaccinia

Generalized vaccinia is an uncommon systemic complication of smallpox vaccination characterized by widespread cutaneous dissemination of the live vaccinia virus, most frequently occurring in primary vaccine recipients. Read more about Generalized vaccinia

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Generalized vaccinia therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Generalized vaccinia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Generalized vaccinia.

Generalized vaccinia is an uncommon systemic complication of smallpox vaccination characterized by widespread cutaneous dissemination of the live vaccinia virus, most frequently occurring in primary vaccine recipients.

Pathophysiologically, the condition results from transient hematogenous dissemination (viremia) from the primary inoculation site rather than accidental autoinoculation.

Clinically, it manifests six to nine days post-vaccination as a generalized maculopapular, vesicular, or pustular rash on normal skin, often accompanied by systemic symptoms such as fever, malaise, and headache.

While generalized vaccinia is typically benign and self-limiting in immunocompetent individuals, it can present with a severe or protracted course in patients with underlying immunodeficiency.

Personalize your experience

Follow Generalized vaccinia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it